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Laboratory red blood cell (RBC) measurements are clinically important, heritable and differ among ethnic
groups. To identify genetic variants that contribute to RBC phenotypes in African Americans (AAs), we con-
ducted a genome-wide association study in up to ∼16 500 AAs. The alpha-globin locus on chromosome
16pter [lead SNP rs13335629 in ITFG3 gene; P < 1E213 for hemoglobin (Hgb), RBC count, mean corpuscular
volume (MCV), MCH and MCHC] and the G6PD locus on Xq28 [lead SNP rs1050828; P < 1E 2 13 for Hgb, hem-
atocrit (Hct), MCV, RBC count and red cell distribution width (RDW)] were each associated with multiple RBC
traits. At the alpha-globin region, both the common African 3.7 kb deletion and common single nucleotide
polymorphisms (SNPs) appear to contribute independently to RBC phenotypes among AAs. In the 2p21
region, we identified a novel variant of PRKCE distinctly associated with Hct in AAs. In a genome-wide admix-
ture mapping scan, local European ancestry at the 6p22 region containing HFE and LRRC16A was associated
with higher Hgb. LRRC16A has been previously associated with the platelet count and mean platelet volume
in AAs, but not with Hgb. Finally, we extended to AAs the findings of association of erythrocyte traits with
several loci previously reported in Europeans and/or Asians, including CD164 and HBS1L-MYB. In summary,
this large-scale genome-wide analysis in AAs has extended the importance of several RBC-associated gen-
etic loci to AAs and identified allelic heterogeneity and pleiotropy at several previously known genetic loci
associated with blood cell traits in AAs.
INTRODUCTION
Laboratory red blood cell (RBC) measurements are important
for the diagnosis and classification of various hematologic dis-
orders. Some disorders of RBCs, such as sickle cell anemia
and alpha thalassemia, are single-gene diseases with higher
frequency among populations of African descent (1,2). Even
among healthy individuals, African Americans (AAs) have
lower hemoglobin (Hgb), hematocrit (Hct) and mean corpus-
cular volume (MCV) compared with other racial/ethnic
groups across all ages (3–5).
Heritability studies suggest that RBC traits are under signifi-
cant genetic influence. Genome-wide association studies
(GWASs) of RBC indices have been reported among
European and Japanese populations (6–8), but to our knowl-
edge have not yet been reported for AA. In a gene-centric
association study from the CARe consortium, the common
African glucose-6-phosphate dehydrogenase (G6PD) A-variant
on chromosome X and another variant of the a-globin
(HBA2-HBA1) locus were associated with multiple RBC traits
in AAs (9).
The genetic loci reported to date explain only a small frac-
tion of heritability in RBC traits, highlighting the need for
larger studies that include ethnic minorities and complemen-
tary analytic approaches (10). Thus, we performed a GWA
meta-analysis of RBC traits among AA participants from
cohorts of the Continental Origins and Genetic Epidemiology
Network (COGENT). As AAs are an admixed population, the
resulting genomic architecture can be leveraged to identify
regions where either African or European ancestral alleles
are associated with traits such as Hgb which differ significant-
ly between European and African populations. Therefore, we
performed admixture mapping for the association between
available RBC traits (Hgb, Hct, MCHC) and local ancestry.
RESULTS
Descriptive analysis
Since not all RBC traits were available in every COGENT
cohort, the numbers of individuals available for meta-analysis
varied by each RBC trait (Supplementary Material, Table S1).
Only Hgb (n ¼ 16 485) and Hct (n ¼ 16 496) were available in
all cohorts. MCHC (n ¼ 12 152), MCV (n ¼ 6438), RBC
count (4818), MCH (n ¼ 4066) and RDW (n ¼ 3811) were
available in subsets of participating cohorts. There were
varying degrees of pairwise correlation between RBC traits
(Supplementary Material, Table S2). Pearson’s correlation
coefficients were highest (.0.95) between Hgb and Hct, and
between MCV and MCH and were lowest between the
RDW and RBC count (0.03).
GWAS of RBC traits in COGENT AAs
The GWA results for each RBC trait are summarized by Man-
hattan (Fig. 1) and quantile–quantile (Supplementary Mater-
ial, Fig. S1) plots. The meta-analysis inflation factors were
all near unity (0.998–1.005), suggesting that confounders
and other technical artifacts were well-controlled. In total,
seven independent genomic loci met the experiment-wide sig-
nificance threshold (P , 1 × 1028) for one or more RBC traits
(Table 1 and Supplementary Material, Table S3). Three loci
(1p31.1, 13q31.2, 16p13.3centromeric) have not been previ-
ously associated with RBC traits, whereas four loci (2p21,
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6q21, 16p31.3telomeric, and Xq28) have been associated with
at least one such trait in populations of European, Japanese or
African descent.
Previously reported RBC loci
The two top Xq28 single nucleotide polymorphisms (SNPs)
(rs762516, rs1050828) for Hgb, Hct, MCV and RBC count
are located in the G6PD gene. rs1050828 encodes the G6PD
amino acid substitution Val68Met that results in the G6PD
A2 allele known to cause G6PD deficiency (MIM #305900).
The G6PD A-variant has been previously associated with
lower Hct, Hgb and RBC count, and with higher MCV in
AAs (9). Here, we additionally report that the G6PD A2
allele is associated with the lower RDW. Given the extent of
the association signal at Xq28, we repeated the Hgb and Hct
association analyses in women from Women Health Initiative
(WHI), the largest AA cohort (n ¼ 8304) for Hgb and condi-
tioning the lead SNPs, rs1050828. After adjusting for
rs1050828, the strength of association with Hgb for the
remaining SNPs on Xq28 was greatly attenuated and no
longer significant (data not shown).
The index SNP on 16p13, which encompasses the a-globin
(HBA2-HBA1) locus, was rs13335629 within an intron of
ITFG3. rs13335629 met the genome-wide significance thresh-
old for association with lower Hgb, MCH, MCHC and
MCV and also with a higher RBC count. The rs13335629
variant was also nominally associated with lower Hct
(b ¼ 20.215+0.056; P ¼ 1.33E204) and higher RDW
(b ¼ 0.0053+0.0021; P ¼ 0.01). Lo et al. previously reported
a common rs1211375 variant within the 16p13 region asso-
ciated with lower Hgb, MCH and MCV in AAs, and that
these associations were not present in Caucasians (9). Our
index SNP rs13335629 is in moderate linkage disequilibrium
(LD) with rs1211375 (r2 ¼ 0.33 in HapMap YRI).
Three intronic variants of the protein kinase C (PKC)-
epsilon gene PRKCE on 2p21 were associated with lower
Figure 1. Manhattan plots of GWAS analysis for RBC traits (A) Hct; (B) Hgb; (C) MCHC; (D) MCH; (E) MCV; (F) RBC count and (G) RDW. The dashed
horizontal red line indicates P ¼ 1 × 1028. The dashed horizontal blue line indicates P ¼ 5 × 1023.
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Hct. The index SNP rs13008603 was also nominally asso-
ciated with a lower RBC count (b ¼ 20.044+ 0.013; P ¼
4.69E204), but not with other RBC traits (P . 0.05 for
Hgb, MCV, MCH, MCHC, RDW). The three Hct-associated
PRKCE variants are in strong LD (pairwise r2 . 0.7).
Another intronic variant of PRKCE (rs10495928) was previ-
ously associated with Hgb and Hct in Europeans (8) and
with the RBC count in Japanese (6), but showed no evidence
of association in AAs (P ¼ 0.50 and 0.71 for Hct and Hgb, re-
spectively). In European and African HapMap populations,
there is no evidence of LD between rs10495928 and any of
the three Hct-associated variants observed in COGENT AA.
These results strongly suggest ethnicity-specific allelic hetero-
geneity for RBC traits at the PRKCE locus.
At 6q21, a haplotype comprised of 10 SNPs (lead SNP ¼
rs9386791) was associated with a lower MCH, and nominally
with a lower MCV (P ¼ 1.09E205), Hgb (P ¼ 0.007), Hct
(P ¼ 0.03), MCHC (P ¼ 0.02), RBC count (P ¼ 0.01).
These variants are located 50 kb upstream of CD164,
which encodes a mucin-like molecule expressed by human
CD34(+) hematopoietic progenitor cells that regulate erythro-
poiesis. Other variants of the CD164 5′ flanking region have
been associated with RBC, MCH and MCV in Japanese
(rs11966072) (6) and with MCV in Europeans (rs9374080)
(8). In HapMap CEU, rs9374080 is in LD with our AA
index SNP rs9386791 (r2 ¼ 0.87).
Newly discovered RBC loci
Of the three novel loci associated with RBC traits, rs10493739
at 1p31.1 (associated with RDW) and rs9559892 at 13q31.2
(associated with MCH) are both located in regions devoid of
known genes. TTLL7 is the closest gene to rs10493739
(400 kb away) and encodes a tubulin polyglutamylase, which
modifies beta-tubulin (11). There are no known genes within
500 kb on either side of rs9559892. The lead SNP at the
third locus, rs7192051 is located within the second intron of
the heme oxygenase-2 gene (HMOX2) and was associated
with lower MCH and MCV. Heme oxygenase 2, the protein
product of HMOX2, degrades heme and is important in
erythropoiesis (12). Although HMOX2 is located 4 Mb cen-
tromic to the alpha-globin locus, it is not in LD with the pre-
viously identified 16p13 association signals (maximum r2 ¼
0.004 with rs13335629).
We attempted to validate two of our three novel RBC loci
discovered in COGENT in two independent population-based
samples: 7700 AA youths ages 8–21 years from CHOP and
2010 AA adults from the Mount Sinai eMERGE study. There
was no evidence of replication of rs9559892 with MCH, nor of
rs7192051 with MCV or MCH (Supplementary Material,
Table S4) in the validation sample. It was not possible to
pursue replication of rs10493739 in CHOP and eMERGE
because this SNP was not genotyped and it could not be
imputed in the available replication samples. In over 20 000
Table 1. Results of genome-wide significant SNPs for RBC traits in COGENT AA
Trait Chromo-some Number of
SNPs with








MAF Effect size (SE) P-value
HCT Xq28 6 rs762516 153 417 857 G6PD, TKTL1, MECP2,
MPP1
T/C 0.148 20.452 (0.055) 2.17E 2 16
HCT 2p21 3 rs13008603 46 209 352 PRKCE A/C 0.163 20.277 (0.047) 4.09E 2 09
HGB 16p13.3 11 rs13335629 250 381 ITFG3, LUCL7, NPRL3,
POLR3K, RPL2B,
MPG
A/G 0.120 20.190 (0.019) 2.63E 2 23
HGB Xq28 9 rs762516 153 417 857 G6PD, TKTL1, MECP2,
MPP1
T/C 0.146 20.1614 (0.0186) 3.73E 2 18
MCHC 16p13.3 38 rs13335629 250 381 ITFG3, LUCL7, NPRL3,
POLR3K, RPL2B,
MPG, NME4, DECR
A/G 0.117 20.3298 (0.0227) 8.66E 2 48
MCH 16p13.3 28 rs13339636 238 589 ITFG3, LUCL7, NPRL3,
POLR3K, RPL2B,
MPG, NME4, DECR
G/A 0.132 20.6847 (0.0559) 1.87E 2 34
MCH 13q31.2 4 rs9559892a 88 166 665 – A/C 0.253 20.2589 (0.0444) 5.46E 2 09
MCH 16p13.3 1 rs7192051a 4 482 118 HMOX2 G/T 0.360 20.2396 (0.0411) 5.70E 2 09
MCH 6q21 10 rs9386791 109 715 190 CD164 C/T 0.416 20.2294 (0.0401) 1.20E 2 08





A/G 0.134 20.648 (0.0669) 3.61E 2 22
MCV Xq28 6 rs762516 153 417 857 G6PD, FAM3A, F8,
MPP1
T/C 0.137 1.5768 (0.2083) 3.76E 2 14
MCV 16p13.3 1 rs7192051a 4 482 118 HMOX2 G/T 0.363 20.259 (0.0475) 4.83E 2 08
RBC 16p13.3 12 rs13335629 250 381 ITFG3, LUCL7 A/G 0.120 0.1699 (0.0169) 7.48E 2 24
RBC Xq28 9 rs1050828 153 417 411 G6PD, F8, MPP1,
MECP2, CTAG2
T/C 0.108 20.1424 (0.0159) 4.00E 2 19
RDW Xq28 1 rs1050828 153 417 411 G6PD T/C 0.116 20.0326 (0.0048) 1.70E 2 11
RDW 1p31.1 1 rs10493739a 83 698 745 – T/C 0.334 0.0128 (0.0023) 3.02E 2 08
aNovel loci.
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Europeans from the CHARGE consortium and 14 000 Japa-
nese from RIKEN, there was no evidence of association of
rs9559892 with MCH. Similarly, there was no evidence of as-
sociation of rs7192051 with MCV or MCH in CHARGE Eur-
opeans (Supplementary Material, Table S4).
Admixture mapping analysis of Hgb, Hct and MCHC
traits in WHI AA
As a complementary approach to identifying variants asso-
ciated with RBC traits in AAs that occur at disparate frequen-
cies in ancestral African versus European populations, we
performed admixture mapping for Hgb, Hct and MCHC in
WHI, the largest cohort comprising COGENT. For MCHC,
there was one genome-wide significant association signal at
the p-term of 16 containing the alpha-globin locus (Supple-
mentary Material, Fig. S2). Local African ancestry in this
region was associated with lower MCHC. The admixture
association peak is at rs7203694 (P ¼ 2.78e206) located
within RAB40C, and the genome-wide significant region spans
0–0.78 mb (build 36). There were no genome-wide significant
admixture associations for Hct (data not shown). For Hgb, a
2 mb region on chromosome 6p22.2–6p22.1 (25.2–27.1 mb,
build 36) reached genome-wide significance, with increased
European ancestry associated with higher Hgb levels
(Fig. 2A). The Hgb admixture signal appears to be comprised
of two peaks (Fig. 2B). Underlying the centromeric peak is
HFE, the hemochromatosis protein-coding gene, which regu-
lates iron absorption by modulating the interaction of the
transferrin receptor with transferrin. Two known HFE muta-
tions C282Y (rs1800562) and H63D (rs1799945) cause heredi-
tary hemochromatosis, an autosomal recessive iron storage
disorder (13). Among individuals of European descent, the fre-
quencies of C282Y and H63D are 3.23 and 16.6 %, respective-
ly. Both the mutations are essentially absent in the HapMap YRI
populations, and therefore the frequency in AAs is low and is the
result of European admixture. C282Y was directly typed in WHI
SHARe and other COGENT cohorts (total N ¼ 15 584); the
genotype association test yielded an Hgb association P ¼
0.0003 in WHI alone and 4.3 × 1026 in COGENT overall
(minor allele frequency ¼ 0.015; b ¼ 0.239+ 0.052). H63D
was not directly typed; however, it is tagged by rs129128
(r2 ¼ 1.0 in CEU), which was associated with Hgb levels in
WHI (P ¼ 0.008) but not when all COGENT cohorts were ana-
lyzed together (P ¼ 0.07).
After adjusting for genotypes at C282Y and the H63D
proxy rs129128 in WHI, the admixture P value for chromo-
some 6p22 was attenuated, but remained significant (from
3.28 × 1027 to 1.12 × 1024), suggesting the existence of add-
itional variants in this region that contribute to inter-
population differences in Hgb levels. Located within the telo-
meric peak of the admixture signal (Fig. 2B) are a number of
additional variants that have Fst . 0.3, including several near
LRRC16A, which has been associated with both serum trans-
ferrin levels in whites and the platelet count in AAs from
COGENT (14). The most strongly associated LRRC16A
variant rs9356970 is located 25 kb upstream of the 5′ flank-
ing region (MAF ¼ 0.09; b ¼ 0.118+ 0.028; P ¼ 2.7 ×
1025). According to the HapMap, the minor allele is present
in 30% of European chromosomes, but only 2.5% of YRI
chromosomes. In a regression model simultaneously adjusting
for LRRC16A rs9356970 in addition to HFE C282Y and
rs129128, the association signal for local African ancestry at
6p22 was further attenuated, but remained nominally asso-
ciated with lower Hgb (b ¼ 20.058+ 0.029; P ¼ 0.045). To-
gether, these results suggest that several European-derived
alleles in the 6p22 region, including those of HFE and
LRRC16A, may contribute to higher Hgb levels observed in
populations of European descent compared with AAs.
CNV analysis and assessment of allelic heterogeneity at
16p13 alpha-globin region
Given the genetic complexity of the alpha-globin locus on
chromosome 16p13, including the presence of a common
3.7 kb alpha-thalassemia deletion in AAs (15), and the
extent and magnitude of the observed GWAS signal for
RBC traits at 16p13, we assessed structural variation at the
16p13 alpha-globin locus using data from 1000 genomes.
First, we confirmed the presence of a common deletion
(2a3.7) among African Americans (AAs) and West Africans
that removes one alpha-globin gene copy (HBA2)
Figure 2. Admixture scan of Hgb concentration. (A) shows a genome-wide
plot of 2log(P-values) for local-ancestry association with Hgb. The dashed
horizontal line indicates the experiment-wide admixture scan significance
threshold of P , 7 × 1026. (B) indicates a zoom-in of the genome-wide sig-
nificant region on chromosome 6, where there appears to be a broad, bimodal
admixture peak. The region corresponding to the HFE gene is shown in blue.
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(Supplementary Material, Fig. S3). Using pooled sequence data
from 16 samples (9 YRI, 5 LWK, 1 ASW, 1 CLM) that appear to
be homozygous for 2a3.7 deletion, we further localized the
breakpoints, which appear to be bounded by 300 bp of
nearly identical sequence located within the 5′ flanking
regions of HBA1 and HBA2 (Supplementary Material,
Fig. S4). Second, we identified a rare deletion spanning HBM
through HBQ1, in three Han Chinese individuals, and several
other possible (but uncertain) rare copy number variations
(CNVs) including one duplication (Supplementary Material,
Fig. S5) and a very rare deletion that deletes a known regulatory
element MCS-R1 (16) (Supplementary Material, Fig. S6).
Among all typed and imputed SNPs in the WHI dataset, the
strongest correlation with alpha37 in 63 YRI samples from
1000 Genomes was observed in the region of ITFG3. This
includes rs13335629 (r-squared ¼ 0.6), which is also the top
Hgb- and MCHC-associated SNP in COGENT AA. We
repeated the association analyses in WHI (n ¼ 8304) for
Hgb and MCHC conditioning on rs13335629. The top SNP
for Hgb in the conditional analysis was POLR3K rs798693
(P ¼ 8.7E206). For MCHC, rs2541612 in NPRL3 remained
genome-wide significantly associated with lower MCHC
(P ¼ 1.14E209). When both ITFG3 rs13335629 and NPRL3
rs2541612 were included as covariates in the conditional ana-
lysis, the SNP most strongly associated with lower MCHC was
LUC7L rs1211375 (P ¼ 1.50E206). Taken together, the 1000
Genomes CNV analyses and the results of conditional regres-
sion analyses for Hgb and MCHC suggest that while some of
the red cell GWAS association signal may be due to the
common African alpha37 deletion, there appears to be inde-
pendent signals coming from other structural variants and/or
SNP(s) in the region.
Cross-ethnic transferability of previously reported RBC to
COGENT AA
We assessed whether 72 SNPs previously associated with
RBC traits in European or Japanese populations are associated
with RBC traits in COGENT AA (Supplementary Material,
Table S5). Using the conservative Bonferroni multiple com-
parison corrected significance threshold (P , 0.0001), we
validated four associations. In addition to the association of
HFE rs1800562 with Hgb, these include ITFG3 rs1122794
(previously associated with MCH in Europeans) with higher
MCHC (P ¼ 1.5 × 1028), MCH (P ¼ 7.2 × 1026) and MCV
(P ¼ 7.1 × 1025) in AAs; ITFG3 rs7189020 (previously asso-
ciated with MCV in Europeans) with higher MCH (P ¼ 1.0 ×
1025) and MCV (P ¼ 1.5 × 1025) in AAs; and HBS1L-MYB
rs7775698 (previously associated with HCT, MCH, MCHC,
MCV and RBC count in Japanese) with a lower RBC count
(P ¼ 3.3 × 1025) in AAs.
RBC-associated genetic variants and anemia in AA women
To identify genetic variants associated with anemia, defined
dichotomously as Hgb , 12 g/dl, we performed a GWA
scan in 8304 AA women 50–79 years old from WHI. Two
loci, Xq28 and 16p13, met the threshold of genome-wide sig-
nificance. The G6PD rs1050828 A-variant was associated with
a 1.49-fold (95% CI: 1.33–1.67) increased risk of anemia
(P ¼ 3.3 × 10212). The index SNP at 16p13 (rs1088638) is
located 20 kb 3′ to POLR3K, and was associated with a
1.42-fold (95% CI: 1.26–1.60) increased risk of anemia
(P ¼ 1.2 × 1028). We also constructed a composite RBC
genetic risk score (GRS) by summing genotyped or imputed
allele dosage at the 15 SNPs associated with at least one
RBC trait in AA through the GWA scan, admixture
mapping scan, conditional analyses or cross-ethnic transfer-
ability analyses described above. The GRS ranged from 5 to
19, with a median of 12. When modeled as a quantitative
trait, the GRS was strongly associated with anemia (P ¼
3.5 × 10218), explaining 1.4% of the anemia phenotypic vari-
ance, or 2.2% of the variance in Hgb concentration. When
WHI participants were grouped into four GRS categories,
those in the highest GRS category had a 1.95-fold increased
risk of anemia (95% CI: 1.56–2.42) compared with those in
the lowest GRS category (P ¼ 3.6 × 1029).
DISCUSSION
In this first reported GWAS meta-analysis of RBC traits in
AAs, we report genome-wide associations for four loci
(G6PD on Xq28, alpha-globin locus on 16pter, PRKCE on
2p21 and CD164 on 6q21). We also validated the association
in AAs of variants in genes such as HFE and HBS1L-MYB,
which have previously been associated with RBC traits in
other ethnicities. At the alpha-globin locus, there appears to
be allelic heterogeneity (particularly for MCHC), with both
copy number variants and SNPs having apparent independent
effects. At PRKCE, the variants associated with lower Hct in
our AA sample appear to be distinct from another set of
PRKCE variants that have been associated with Hgb, Hct
and RBC count in Europeans and Japanese.
Hemizygous males and in some instances female carriers of
the X-linked G6PD A- allele are predisposed to acute episodes
of drug- or infection-induced hemolytic anemia. Under basal
conditions, however, the G6PD A-allele is not generally
thought to be associated with RBC abnormalities, and hemizy-
gous G6PD A-individuals have been reported to have normal
baseline red cell survival in the absence of oxidant stress (17).
Nonetheless, the association of low RDW with G6PD defi-
ciency may be due to low grade hemolysis resulting in an in-
crease in the MCV with rightward shift of the overall
distribution of RBC volume without change in the shape of
the distribution (18). The G6PD A-variant is in LD with
other nearby genetic variants that plausibly could influence
Hgb or RBC morphology. TKTL1 encodes a transketolase
enzyme that links the pentose phosphate pathway with anaer-
obic glycolysis, which constitutes the two major metabolic
pathways for glucose utilization in human erythrocytes.
MPP1 encodes the red cell membrane protein p55, a scaffold-
ing protein that anchors the actin cytoskeleton to the plasma
membrane by forming a ternary complex with protein 4.1R
and glycophorin C (19).
Aside from genes involved in Hgb synthesis or metabolism,
other genetic loci such as CD164 and PRKCE may be asso-
ciated with RBC traits through effects on erythropoiesis.
CD164 (endolyn) is an adhesive receptor present on early
hematopoietic progenitors and maturing erythroid cells that
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regulates the adhesion of CD34+ cells to bone marrow stroma
and affects migration and proliferation of hematopoietic stem
cells and progenitor cells (20,21). The upstream region harbor-
ing the RBC trait-associated variants contains an erythroleuke-
mia cell line (K562)-specific cluster of histone modifications
and ENCODE transcription factor ChIP-seq binding sites in-
cluding those for GATA-2 and c-Jun. PRKCE encodes an
isoform of PKC, PKC epsilon, which is expressed in hemato-
poietic progenitor cells in a lineage- and stage-specific manner
and appears to influence erythroid and megakaryocytic pro-
genitor proliferation and differentiation by modulating the re-
sponse of hematopoietic precursors to a tumor necrosis
factor-related apoptosis-inducing ligand (22–24).
Though the finding was not validated in independent AA
samples, one of our novel genome-wide significant associa-
tions in our discovery cohorts was the association of MCH
and MCV with HMOX2, which encodes heme oxygenase-2,
a constitutively expressed enzyme with a major role in heme
catabolism. Heme induces expression of globin genes in
erythrocyte progenitor cells and thus plays an important role
in erythropoiesis (12,25,26). The lead SNP in this region,
rs7192051, is within 5 kb of predicted HMOX2 regulatory ele-
ments such as transcription factor binding sites, DNase sites
and histone modification sites (27). Therefore, further study
of this variant in larger, independent samples of AA may be
warranted.
Our findings have potential clinical implications. Although
previous studies have explored the role of common genetic
variation in the regulation of these RBC phenotypes in popu-
lations of European and Asian descent (6,7,10), no systematic
genetic association studies of these traits have been reported in
African-ancestry populations. This is particularly important, as
there are marked differences in these RBC indices among
ethnic groups, and anemia is more prevalent in populations
of African descent (28). While it appears that some of the
phenotypic variations for RBC and other hematologic traits
are controlled by genetic variation shared across ethnic
groups (29), other RBC loci are relatively unique to Africans.
Rare variants, which are not well captured by GWASs, and un-
detected common variants of more modest effect may account
for additional genetic variance. Discovery and validation of
these and additional genetic variants associated with RBC
traits in other ethnic populations are likely to uncover new
mechanisms and pathways that affect hematopoiesis and
RBC turnover, offering insights that may inform further re-
search into red cell biology. Indeed, recent reports have
shown that genetic loci uncovered through an unbiased
genome-wide study in human populations, together with
follow-up functional studies incorporating gene expression,
bioinformatic analyses and insights from mouse models and
gene knockdown experiments, can greatly contribute to our
understanding of the biological mechanisms underlying RBC
production (30,31).
MATERIALS AND METHODS
Primary subjects and data collection
We performed GWA analysis of RBC traits in over 16 000
AAs from seven population-based cohorts that comprise the
Continental Origins and Genetic Epidemiology Network
(COGENT). The characteristics of each cohort were described
in previous publications (14,29). Fasting blood samples were
drawn and analyzed for RBC traits at designated clinical la-
boratories using an automated electronic cell counter. These
counters directly measure Hgb concentration (in grams per
deciliter), RBC count (in millions per microliter) and MCV,
the average size of the RBC in femtoliters. Electronic cell
counters calculate MCH, MCHC, Hct and RDW. Hct is the
percentage of blood by volume that is occupied by RBC and
is calculated by multiplying the RBC count in millions/micro-
liter by the MCV in femtoliters. MCH is the average amount
of Hgb inside an RBC expressed in picograms and is calcu-
lated by dividing the Hgb concentration by the RBC count
in millions per microliter, then multiplying by 10. The
MCHC is the average concentration of Hgb in RBCs and is
calculated by dividing Hgb in grams per deciliter by Hct.
The RDW is a measure of the variance in RBC size and is cal-
culated by dividing the standard deviation of RBC volume by
the MCV and multiplying by 100.
All participants self-reported their race/ethnicity. Additional
clinical information was collected by self-report and clinical
examination. Participants provided written informed consent
as approved by local Human Subjects Committees. Study par-
ticipants who were pregnant or had a diagnosis of cancer or
AIDS at the time of blood count were excluded.
Replication subjects and data collection
For validation of novel, genome-wide significant associations
identified in the COGENT discovery sample, we performed
association analyses in two independent population-based
samples: 7700 AA youths ages 8–21 years from Children’s
Hospital of Philadelphia (CHOP) and 2010 AA adults from the
Mount Sinai electronic Medical Records and Genomics
(eMERGE) study. We also attempted to replicate novel loci in
two other ethnic populations: 14 088 Japanese from RIKEN
and up to 30 000 European Americans from CHARGE.
Details of each validation cohort are provided under Supple-
mentary Material.
Genotyping and quality-control
Genomic DNA was extracted from peripheral blood leuko-
cytes and genotyping was performed on the Affymetrix 6.0
array or Illumina Omni or 1 M platforms within each cohort
using methods described previously (14,29). DNA samples
with a genome-wide genotyping success rate of ,90% or
sex discordance were excluded, as were genetic ancestry out-
liers (identified by cluster analysis using principal components
analysis or multi-dimensional scaling). SNPs with a genotyp-
ing success rate of ,95% or MAF ,1%, monomorphic SNPs
and SNPs that map to several genomic locations were removed
from the analyses. Participants and SNPs passing basic quality
control thresholds were imputed to .2.2 million autosomal
SNPs based on HapMap2 haplotype data using a 1:1 mixture
of Europeans (CEU) and Africans (YRI) as the reference
panel. Details of the genotype imputation procedure have
been described previously (14,29). Prior to discovery meta-
analyses, SNPs were excluded if imputation quality metrics
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(equivalent to the squared correlation between proximal
imputed and genotyped SNPs) were ,0.30.
Data analyses
For all cohorts, GWA analysis was performed on the raw,
untransformed RBC trait using linear regression adjusted
for covariates, implemented in either PLINK v1.07 or
MACH2QTL v1.08. In GeneSTAR, the family structure was
accounted for in the association tests using linear mixed-
effects models implemented in R (32). For the 22 autosomes,
analysis was performed using genotyped and imputed SNPs.
For the X chromosome, only genotyped SNPs were analyzed
due to the technical limitations of imputing X-linked SNPs.
All analyses were performed under an additive genetic
model using allelic dosage (genotyped or imputed) at each
SNP, adjusted for age, age-squared, sex and clinic site (if ap-
plicable), 4–10 principal components.
For each phenotype, meta-analysis was conducted using
inverse-variance weighted fixed-effects models to combine b
coefficients and standard errors from study-level regression
results for each SNP, to derive pooled estimates. Study-level
results were corrected for genomic inflation factors (l)
by multiplying the standard errors (SEs) of the regression
coefficients by the square-root of the study-specific l.
Meta-analyses were implemented in the METAL software.
Between-study heterogeneity of results was assessed by
using Cochran’s Q statistic and the I2 inconsistency metric.
A threshold of a ¼ 1 × 1028 was used to declare genome-
wide statistical significance. This statistical threshold accounts
for the greater nucleotide diversity and lower LD in African
descent populations combined with testing of multiple, corre-
lated RBC traits (31,33). We carried out replication testing of
‘suggestive’ SNPs selected on the basis of a more liberal
significance threshold in our primary AA discovery GWAS
(P , 5 × 1028).
To assess the potential existence of multiple, independent
variants influencing a trait at the same locus (allelic heterogen-
eity), regression analyses were repeated in the largest sample
(WHI, n ¼ 8095), conditional on the most strongly associated
(index) SNP in that region.
We also assessed the transferability to AAs of SNPs previ-
ously associated with RBC traits in populations of European or
Japanese ancestry by assessing association with RBC traits in
the COGENT discovery meta-analyses. For validation, we
considered consistency of direction of effect, and assessed
statistical significance using a simple Bonferroni adjustment
for the total number of SNPs assessed, using a two-sided hy-
pothesis test.
Local ancestry estimation and admixture mapping in WHI
For each AA individual in the WHI sample, locus-specific an-
cestry was estimated using an extension of the model
described by Tang et al. (34). We used phased haplotype
data from HapMap3 CEU and YRI individuals as reference
panels. An admixture mapping analysis was performed in
WHI to test for association between Hgb levels and ancestry
at each genomic location (local ancestry), while adjusting
for the first 10 principal components, regions of recruitment,
clinical trial, age and age-squared. The critical value for
genome-wide significance level of admixture mapping is sub-
stantially lower than the genotype test due to the extensive
correlation in local ancestry between adjacent markers that
result from the recent admixture in AAs. We therefore
adopted an empirically determined genome-wide significance
threshold of P , 7.1 × 1026, which corresponds to a Bonfer-
roni correction of 7000 independent tests (35).
Copy number variation (CNV) analysis using 1000
genomes data
We used the 1000 Genomes sequencing data to investigate
CNVs at the chromosome 16 p31 alpha-globin locus, studying
946 African-ancestry samples at roughly 4× sequencing
coverage. As a result of noise in depth-based genotyping at
this locus (due to low-pass sequencing, high %GC and poten-
tial overlapping variants), some of our analyses were confined
to the 76 YRI samples, which have higher sequence coverage
in 1000 Genomes data and more complete genotyping (call
rate 84 % at 95 % CI).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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